ADHFE1 and gastric cancer: We validated the prognostic value of ADHFE1 in the TCGA-STAD dataset using SurvExpress that patients with gastric cancer in low-risk subgroup had higher expression of ADHFE1 than those in the high-risk subgroup (P = 3.77 × 10−114; Figure 5g).